CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Ironwood
Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host
its third quarter 2011 investor update conference call and webcast at
4:30 p.m. Eastern Time on Monday, November 7, 2011. Individuals
interested in participating in the call should dial (888) 663-2242 (U.S.
and Canada) or (913) 312-1516 (international) using conference ID number
3637845. To access the webcast, please visit the Investors section of
Ironwood's website at www.ironwoodpharma.com
at least 15 minutes prior to the start of the call to ensure adequate
time for any software downloads that may be required.
The call will be available for replay via telephone starting November 7,
2011, at approximately 7:30 p.m. Eastern Time, running through 11:59
p.m. Eastern Time on November 21, 2011. To listen to the replay, dial
(888) 203-1112 (U.S. and Canada) or (719) 457-0820 (international) using
conference ID number 3637845. The archived webcast will be available on
Ironwood's website for 14 days beginning approximately one hour after
the call.
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial
pharmaceutical company dedicated to the art and science of great
drugmaking. Linaclotide, Ironwood's GC-C agonist, is an investigational
drug for the treatment of irritable bowel syndrome with constipation
(IBS-C) and chronic constipation (CC). The efficacy portion of
linaclotide's development program has been completed and supports the
recently submitted NDA submission for both indications, as well as the
MAA submission in Europe for the IBS-C indication. Ironwood also has a
growing pipeline of additional drug candidates in earlier stages of
development. Ironwood is located in Cambridge, Mass. To learn more,
visit www.ironwoodpharma.com.
Ironwood Pharmaceuticals, Inc.
Susan Brady, 617-621-8304
Corporate
Communications
sbrady@ironwoodpharma.com
Source: Ironwood Pharmaceuticals, Inc.
News Provided by Acquire Media